In vitro pre- and post-exposure prophylaxis using HIV inhibitors as microbicides against cell-free or cell-associated HIV-1 infection (Q39518073)

12 September 2017

In vitro pre- and post-exposure prophylaxis using HIV inhibitors as microbicides against cell-free or cell-associated HIV-1 infection (English)

1 reference

post-exposure prophylaxis

12 September 2017

1 reference

based on heuristic

inferred from title

author name string

Katty Terrazas-Aranda

1

1 reference

12 September 2017

Yven Van Herrewege

2

1 reference

12 September 2017

Paul J Lewi

3

1 reference

12 September 2017

Jens Van Roey

4

1 reference

12 September 2017

Guido Vanham

5

1 reference

12 September 2017

1 January 2007

1 reference

Antiviral Chemistry & Chemotherapy

12 September 2017

1 reference

12 September 2017

18

1 reference

12 September 2017

3

1 reference

12 September 2017

141-151

1 reference

Mechanisms underlying activity of antiretroviral drugs in HIV-1-infected macrophages: new therapeutic strategies

12 September 2017

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800304

Intravaginal and intrarectal microbicides to prevent HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800304

Design and evaluation of an in-house HIV-1 (group M and O), SIVmnd and SIVcpz antigen capture assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800304

Recent observations on HIV type-1 infection in the genital tract of men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800304

Dawn of non-nucleoside inhibitor-based anti-HIV microbicides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800304

Microbicides to prevent HIV transmission: overcoming obstacles to chemical barrier protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800304

Criteria for drugs used in pre-exposure prophylaxis trials against HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800304

The nonnucleoside reverse transcriptase inhibitor UC-781 inhibits human immunodeficiency virus type 1 infection of human cervical tissue and dissemination by migratory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800304

How do viral and host factors modulate the sexual transmission of HIV? Can transmission be blocked?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800304

Blockade of attachment and fusion receptors inhibits HIV-1 infection of human cervical tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800304

Repeated intravaginal inoculation with cell-associated simian immunodeficiency virus results in persistent infection of nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800304

Development of topical microbicides for prevention of human immunodeficiency virus and herpes simplex virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800304

Combination of candidate microbicides cellulose acetate 1,2-benzenedicarboxylate and UC781 has synergistic and complementary effects against human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800304

Cellulose acetate 1,2-benzenedicarboxylate inhibits infection by cell-free and cell-associated primary HIV-1 isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800304

Prioritizing prevention of HIV and sexually transmitted infections: first-generation vaginal microbicides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800304

Sex differences in the transmission, prevention, and disease manifestations of sexually transmitted diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800304

Spirodiketopiperazine-based CCR5 inhibitor which preserves CC-chemokine/CCR5 interactions and exerts potent activity against R5 human immunodeficiency virus type 1 in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800304

HIV binding, penetration, and primary infection in human cervicovaginal tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800304

A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800304

Efficacy of postexposure prophylaxis after intravaginal exposure of pig-tailed macaques to a human-derived retrovirus (human immunodeficiency virus type 2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800304

HIV/AIDS in women: an expanding epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800304

Maternal single-dose nevirapine versus placebo as part of an antiretroviral strategy to prevent mother-to-child HIV transmission in Botswana

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800304

Inhibiting sexual transmission of HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800304

Evaluating the potential impact of vaginal microbicides to reduce the risk of acquiring HIV in female sex workers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800304

HIV-1 entry inhibitors: classes, applications and factors affecting potency

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800304

Chemoprophylaxis with tenofovir disoproxil fumarate provided partial protection against infection with simian human immunodeficiency virus in macaques given multiple virus challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800304

Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800304

Clinical microbicide research: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800304

Activity of reverse transcriptase inhibitors in monocyte-derived dendritic cells: a possible in vitro model for postexposure prophylaxis of sexual HIV transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800304

A series of diaryltriazines and diarylpyrimidines are highly potent nonnucleoside reverse transcriptase inhibitors with possible applications as microbicides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800304

In vitro evaluation of nonnucleoside reverse transcriptase inhibitors UC-781 and TMC120-R147681 as human immunodeficiency virus microbicides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800304

Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800304

Use of a small molecule CCR5 inhibitor in macaques to treat simian immunodeficiency virus infection or prevent simian-human immunodeficiency virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800304

Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800304

Synergistic in vitro antiretroviral activity of a humanized monoclonal anti-CD4 antibody (TNX-355) and enfuvirtide (T-20).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800304

Blocking of cell-free and cell-associated HIV-1 transmission through human cervix organ culture with UC781.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800304

Novel Strategies in HIV Prevention-Development of Topical Microbicides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800304

10.1177/095632020701800304

21 January 2018

Identifiers

DOI

1 reference

12 September 2017

1 reference